Canada markets closed

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.24+0.39 (+0.89%)
At close: 04:00PM EDT
43.31 -0.93 (-2.10%)
After hours: 04:05PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.64B
Enterprise Value 3.11B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.49
Price/Book (mrq)13.23
Enterprise Value/Revenue 7.16
Enterprise Value/EBITDA -6.02

Trading Information

Stock Price History

Beta (5Y Monthly) 0.66
52-Week Change 30.48%
S&P500 52-Week Change 322.36%
52 Week High 354.98
52 Week Low 331.52
50-Day Moving Average 347.79
200-Day Moving Average 342.13

Share Statistics

Avg Vol (3 month) 3696.56k
Avg Vol (10 day) 3798.68k
Shares Outstanding 582.34M
Implied Shares Outstanding 682.34M
Float 872.17M
% Held by Insiders 14.11%
% Held by Institutions 1101.15%
Shares Short (Apr 15, 2024) 44.38M
Short Ratio (Apr 15, 2024) 46.09
Short % of Float (Apr 15, 2024) 45.54%
Short % of Shares Outstanding (Apr 15, 2024) 45.32%
Shares Short (prior month Mar 15, 2024) 43.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -139.70%
Operating Margin (ttm)-95.81%

Management Effectiveness

Return on Assets (ttm)-23.43%
Return on Equity (ttm)-193.23%

Income Statement

Revenue (ttm)434.25M
Revenue Per Share (ttm)5.91
Quarterly Revenue Growth (yoy)23.30%
Gross Profit (ttm)N/A
EBITDA -543.2M
Net Income Avi to Common (ttm)-606.64M
Diluted EPS (ttm)-8.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)577.21M
Total Cash Per Share (mrq)7.01
Total Debt (mrq)934.74M
Total Debt/Equity (mrq)339.39%
Current Ratio (mrq)2.61
Book Value Per Share (mrq)3.35

Cash Flow Statement

Operating Cash Flow (ttm)-474.81M
Levered Free Cash Flow (ttm)-312.22M